BioPharma Dive22h
Praxis hits trial setback; Bristol Myers lays off staff in New Jersey
The brain drug developer is continuing a trial despite a recommendation it be stopped for futility. Elsewhere, Eli Lilly ...
The American Journal of Managed Care21h
5 Rare Diseases That Now Have Their First FDA-Approved Treatments
Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...